Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
No FDA-approved animal drug contains ketoconazole; Animal Drugs@FDA returns no ketoconazole products. Ketoconazole tablets are an FDA-approved human medicine, labeled for certain systemic fungal infections in patients who have failed or cannot tolerate other therapies, and the label carries a boxed warning. The Merck Veterinary Manual describes ketoconazole as an imidazole antifungal, gives oral dosing information for dogs, cats and birds, and notes it is poorly absorbed by mouth in small animals and not absorbed in horses. These are not FDA-approved uses in animals. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The Merck Veterinary Manual says ketoconazole is associated with liver toxicity, especially in cats, and that reproductive disorders may be seen in dogs. It reduces the adrenal glands' response to stimulation, and azole antifungals interfere with the body's handling of steroid hormones such as cortisol and testosterone. The human label's boxed warning describes serious liver injury, including deaths, and dangerous heart rhythm changes when it is combined with certain other drugs. Merck notes ketoconazole slows the breakdown of many other drugs, that rifampin lowers ketoconazole levels, and that giving it with griseofulvin raises the risk of liver injury. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
With no approved animal product, ketoconazole use in animals is extralabel use of an approved human drug, permitted in nonfood-producing animal practice under 21 CFR 530.30 except when public health is threatened; compounding from an approved human product falls under 530.13(b), and 530.13(a) excludes compounding from bulk. Ketoconazole is not on FDA's GFI #256 office stock list; FDA lists it as currently under review for dogs, cats and horses, and reviewed and did not list ketoconazole and triamcinolone combined with an antibiotic for dogs and cats (four otic combinations, 2/28/2023; one with enrofloxacin, 4/10/2026). Merck notes ketoconazole has the broadest cytochrome P450 inhibition of the azoles.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
